Quality of Life in Younger Leukemia and Lymphoma Survivors

Case Comprehensive Cancer Center (Case CCC)

Status: Completed

Conditions: Long-term Effects Secondary to Cancer Therapy in Adults; Lymphoproliferative Disorder; Anxiety Disorder; Psychosocial Effects of Cancer and Its Treatment; Cancer Survivor; Lymphoma; Leukemia; Fatigue; Pain; Small Intestine Cancer

Treatments: Procedure: assessment of therapy complications; Procedure: quality-of-life assessment; Other: questionnaire administration; Procedure: psychosocial assessment and care; Procedure: fatigue assessment and management; Behavioral: telephone-based intervention

Study type: Observational

Funder types: Other; NIH

Identifiers

NCT00956475

CASE11Z08 (Other Identifier)

CASE 11Z08-CC607 (Other Identifier)

P30CA043703 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

RATIONALE: Collecting information about the effect of hematologic cancer and its treatment on quality of life may help doctors learn more about the disease and plan the best treatment.

PURPOSE: This phase I trial is studying quality of life in younger leukemia and lymphoma survivors.

Full description

OBJECTIVES:

• To collect preliminary data to determine the extent to which there is impairment in quality of life of young adult survivors of hematologic malignancies.
• To identify the most common areas of concern in these survivors.
• To explore patterns of quality-of-life impairment associated with age, gender, and type of treatment (transplant vs non-transplant) in these survivors.

OUTLINE: Patients are assessed in a telephone interview using a brief demographic and clinical data form. Patients then undergo quality-of-life assessment by the Cancer Patient/Cancer Survivor Version questionnaire via telephone.

Enrollment: 48 patients

Sex: All

Ages: 18 to 35 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

DISEASE CHARACTERISTICS:

• Survivors of leukemia (i.e., acute myelogenous leukemia, acute lymphoblastic leukemia, chronic myelogenous leukemia, or chronic lymphocytic leukemia) or lymphoma (i.e., non-Hodgkin lymphoma or Hodgkin lymphoma) who have received any cytotoxic or radiation therapy
• Received treatment for leukemia or lymphoma 1-10 years ago

PATIENT CHARACTERISTICS:

• Not specified

PRIOR CONCURRENT THERAPY:

• See Disease Characteristics